BWFG vs REGN · P/E 11, rev $1.4M vs P/E 14, rev $4.29B
Bankwell Financial Group Inc (BWFG) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Bankwell Financial Group Inc (BWFG) is a banks - regional company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported BWFG revenue for 2026-06-30 was $1.4M. Net income was $23.6M. Revenue was up 85.3% from 2026-03-31 to 2026-06-30. BWFG currently screens at market cap $427.9M and trailing P/E 10.8.
Latest reported REGN revenue for 2026-06-30 was $4.29B. Net income was $1.30B. Revenue was up 19.0% from 2026-03-31 to 2026-06-30. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
BWFG currently screens at market cap $427.9M and trailing P/E 10.8. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the BWFG and REGN stock pages for the full models.
Not investment advice.